Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Knutson

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Cancer Immunology, Immunotherapy : CII|August 24, 2015
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancerKeith L Knutson, Matthew J Maurer, Claudia C Preston, et al.
Scientific Reports|March 3, 2021
A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosisEmmanuel M Gabriel, Minhyung Kim, Daniel T Fisher, et al.
Cancer Research|March 12, 2009
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cellsMarta Santisteban, Jennifer M Reiman, Michael K Asiedu, et al.
Cancer Research|May 20, 2016
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular DomainKeith L Knutson, Raphael Clynes, Barath Shreeder, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2015
Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk StratificationPatricio Escalante, Tobias Peikert, Virginia P Van Keulen, et al.
Cancer Research|November 15, 2015
PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κBLavakumar Karyampudi, Purushottam Lamichhane, James Krempski, et al.
Scientific Reports|August 4, 2016
The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant DiseaseTina J Hieken, Jun Chen, Tanya L Hoskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) TrialsSaranya Chumsri, Daniel J Serie, Zhuo Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast CancerSaranya Chumsri, Joseph J Larson, Emily Liu, et al.
Journal for Immunotherapy of Cancer|November 2, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockadeYan Luo, Barath Shreeder, James W Jenkins, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|August 24, 2015
Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancerKeith L Knutson, Matthew J Maurer, Claudia C Preston, et al.
Scientific Reports|March 3, 2021
A pilot trial of intravital microscopy in the study of the tumor vasculature of patients with peritoneal carcinomatosisEmmanuel M Gabriel, Minhyung Kim, Daniel T Fisher, et al.
Cancer Research|March 12, 2009
Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cellsMarta Santisteban, Jennifer M Reiman, Michael K Asiedu, et al.
Cancer Research|May 20, 2016
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular DomainKeith L Knutson, Raphael Clynes, Barath Shreeder, et al.
American Journal of Respiratory and Critical Care Medicine|June 2, 2015
Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk StratificationPatricio Escalante, Tobias Peikert, Virginia P Van Keulen, et al.
Cancer Research|November 15, 2015
PD-1 Blunts the Function of Ovarian Tumor-Infiltrating Dendritic Cells by Inactivating NF-κBLavakumar Karyampudi, Purushottam Lamichhane, James Krempski, et al.
Scientific Reports|August 4, 2016
The Microbiome of Aseptically Collected Human Breast Tissue in Benign and Malignant DiseaseTina J Hieken, Jun Chen, Tanya L Hoskin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2019
Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) TrialsSaranya Chumsri, Daniel J Serie, Zhuo Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2025
Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast CancerSaranya Chumsri, Joseph J Larson, Emily Liu, et al.
Journal for Immunotherapy of Cancer|November 2, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockadeYan Luo, Barath Shreeder, James W Jenkins, et al.
Pageof 15